Titre:
  • Phase i study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors
Auteur:Stuurman, Frederik; Voest, E.E.; Awada, Ahmad; Witteveen, Petronella; Bergeland, T.; Hals, Petter Arnt; Rasch, Wenche; Schellens, Jan J.H.M.; Hendlisz, Alain
Informations sur la publication:Investigational new drugs, 31, 4, page (959-966)
Statut de publication:Publié, 2013-08
Sujet CREF:Cancérologie
Pharmacologie
Mots-clés:Cancer
Capsules
CO-1.01
CP-4126
dFdC
dFdU
Gemcitabine
Lipid
Oral
Oral administration
Phase 1
Phospholipids
MeSH keywords:Administration, Oral
Adult
Aged
Antineoplastic Agents -- administration & dosage -- adverse effects -- pharmacokinetics -- therapeutic use
Demography
Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives -- pharmacokinetics -- therapeutic use
Female
Humans
Male
Middle Aged
Neoplasm Staging
Neoplasms -- drug therapy -- pathology
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0167-6997
info:doi/10.1007/s10637-013-9925-z
info:scp/84880921868
info:pmid/23345000